Trademark: 90127064
Word
CANCER DRUG DEVELOPMENT COMES OF AGE
Status
Dead
Status Code
606
Status Date
Monday, May 2, 2022
Serial Number
90127064
Mark Type
4000
Filing Date
Thursday, August 20, 2020
Published for Opposition
Tuesday, February 2, 2021
Abandoned Date
Monday, May 2, 2022

Trademark Owner History
Day One Biopharmaceuticals, Inc. - Owner At Publication
Day One Therapeutics, Inc. - Original Applicant

Classifications
42 Research and development in the pharmaceutical and biotechnology fields
"CANCER DRUG DEVELOPMENT"

Trademark Events
May 2, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
May 2, 2022
Abandonment - No Use Statement Filed
Feb 15, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 15, 2022
Teas Change Of Correspondence Received
Feb 15, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 15, 2022
Teas Change Of Owner Address Received
Sep 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 28, 2021
Sou Extension 1 Granted
Sep 22, 2021
Sou Extension 1 Filed
Sep 28, 2021
Case Assigned To Intent To Use Paralegal
Sep 22, 2021
Sou Teas Extension Received
Apr 24, 2021
Corrected Noa E-Mailed
Apr 23, 2021
Changes/Corrections After Pub Approval Entered
Apr 22, 2021
Assigned To Petition Staff
Mar 30, 2021
Noa E-Mailed - Sou Required From Applicant
Feb 2, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 2, 2021
Published For Opposition
Jan 15, 2021
Teas Post Publication Amendment Received
Jan 13, 2021
Notification Of Notice Of Publication E-Mailed
Dec 23, 2020
Approved For Pub - Principal Register
Dec 22, 2020
Examiner's Amendment Entered
Dec 22, 2020
Notification Of Examiners Amendment E-Mailed
Dec 22, 2020
Examiners Amendment E-Mailed
Dec 22, 2020
Examiners Amendment -Written
Dec 16, 2020
Assigned To Examiner
Sep 24, 2020
New Application Office Supplied Data Entered
Aug 24, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24